S&P 500

5.469,30

0,39%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
China SXT Pharmaceuticals Inc (SXTC)
China SXT Pharmaceuticals Inc (SXTC) Notícias

SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SXTC

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/05/2024	17:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
11/01/2024	18:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
26/10/2023	17:05	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
04/10/2023	09:30	GlobeNewswire Inc.	China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
31/07/2023	17:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
19/05/2023	18:17	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
10/05/2023	09:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
29/03/2023	15:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
29/03/2023	14:50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
27/03/2023	07:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
28/02/2023	18:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
07/11/2022	10:00	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
18/07/2022	12:02	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
18/05/2022	13:30	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
16/03/2022	09:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
15/03/2022	17:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
14/03/2022	23:33	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
20/01/2022	12:45	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
18/01/2022	08:47	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
14/01/2022	19:43	GlobeNewswire Inc.	China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
14/01/2022	16:30	PR Newswire (US)	China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
18/10/2021	09:00	PR Newswire (US)	China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
19/02/2021	10:00	PR Newswire (US)	China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
11/02/2021	08:08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
09/09/2020	10:00	PR Newswire (US)	NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
22/05/2020	16:50	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
22/04/2020	17:38	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
16/03/2020	10:16	PR Newswire (US)	China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
24/01/2020	16:23	Business Wire	China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production	NASDAQ:SXTC	China SXT Pharmaceuticals Inc
16/01/2020	10:00	PR Newswire (US)	China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory	NASDAQ:SXTC	China SXT Pharmaceuticals Inc